Evidence map›Paper›PMID 27854031›Full record

ArticleEJNMMI research2016

Evaluation of

R Sharma, P Mapelli, G B Hanna, R Goldin, D Power, A Al-Nahhas, S Merchant, R Ramaswami, A Challapalli, T Barwick and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Long-term prognostic value ofCancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

R SharmaDepartment of Surgery and Cancer, Imperial College London, London, UK. r.sharma@imperial.ac.uk.
P MapelliDepartment of Surgery and Cancer, Imperial College London, London, UK.
G B HannaDepartment of Gastro-Oesophageal Surgery, Imperial College Healthcare NHS Trust, London, UK.
R GoldinDepartment of Pathology, Imperial College Healthcare NHS Trust, London, UK.
D PowerDepartment of Oncology, Imperial College Healthcare NHS Trust, London, UK.
A Al-NahhasDepartment of Radiology/Nuclear Medicine, Imperial College Healthcare NHS Trust, London, UK.
S MerchantDepartment of Surgery and Cancer, Imperial College London, London, UK.
R RamaswamiDepartment of Surgery and Cancer, Imperial College London, London, UK.
A ChallapalliDepartment of Surgery and Cancer, Imperial College London, London, UK.
T BarwickDepartment of Surgery and Cancer, Imperial College London, London, UK.
E O AboagyeDepartment of Surgery and Cancer, Imperial College London, London, UK.
Imperial College London · GBImperial College Healthcare NHS Trust · GB

Funding

Cancer Research UK 10337Cancer Research UK 12011Cancer Research UK 16584Department of Health EME/13/122/01Department of Health NIHR/CS/009/009Medical Research Council G0700915Medical Research Council MR/J007986/1Medical Research Council MR/N020782/1
6 · The paper itself

Abstract

background3'-Deoxy-3'-[

resultsTen patients were included. Following application of the KSF, visual distinction of all oesophageal and/or gastric tumours was observed in [

conclusionsThe results of this study indicate that application of the KSF allowed accurate visualisation of both primary and metastatic lesions following imaging with the proliferation marker, [

Indexed as

[18 F]FLT-PETChemotherapyEarly responseGastro-oesophageal cancerRECIST 1.1

Identifiers

PMID27854031
PMCPMC5112222
OpenAlexW2553896360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.